Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
177,577,894
-
Share change
-
+2,590,792
-
Total reported value
-
$15,832,679,554
-
Put/Call ratio
-
61%
-
Price per share
-
$89.17
-
Number of holders
-
431
-
Value change
-
+$224,283,938
-
Number of buys
-
194
-
Number of sells
-
185
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2017
As of 31 Dec 2017,
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) was held by
431 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
177,577,894 shares.
The largest 10 holders included
Capital Research Global Investors, Vanguard Group Inc, BlackRock Inc., JENNISON ASSOCIATES LLC, PRIMECAP MANAGEMENT CO/CA/, SANDS CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, FMR LLC, Invesco Ltd., and STATE STREET CORP.
This page lists
431
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.